Galapagos NV
GLPG
#4838
Rank
NZ$3.28 B
Marketcap
NZ$48.97
Share price
0.49%
Change (1 day)
15.63%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): NZ-$0.80

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is NZ-$0.58. In 2024 the company made an earnings per share (EPS) of NZ$1.99 a decrease over its 2023 EPS that were of NZ$6.05.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$0.80-140.02%
2024NZ$1.99-67.16%
2023NZ$6.05-199.64%
2022NZ-$6.0899.03%
2021NZ-$3.05-68.98%
2020NZ-$9.84-298.06%
2019NZ$4.97-554.64%
2018NZ-$1.09-77.18%
2017NZ-$4.79-326.21%
2016NZ$2.12-134.19%
2015NZ-$6.19-371.34%
2014NZ$2.28-445.98%
2013NZ-$0.6632.88%
2012NZ-$0.50-82.07%
2011NZ-$2.77-817.9%
2010NZ$0.3912.73%
2009NZ$0.34-120.79%
2008NZ-$1.65-37.67%
2007NZ-$2.6439.64%
2006NZ-$1.8928.17%
2005NZ-$1.486.25%
2004NZ-$1.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$19.00-3,384.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.40-1,205.90%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$4.08-805.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$3.52-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
NZ$12.47-2,255.70%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$10.12-1,848.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
NZ$6.43-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
NZ-$1.04 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$2.12-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel